Home Capital Broker's Calls

Why CLCT is a 'buy' despite its weak FY2020 results

Jeffrey Tan
Jeffrey Tan2/3/2021 11:26 AM GMT+08  • 2 min read
Why CLCT is a 'buy' despite its weak FY2020 results
DBS believes that CLCT has “compelling value for a morphing China behemoth”.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Analysts have continued their optimism for CapitaLand China Trust (CLCT), formerly known as CapitaLand Retail China Trust (CRCT), despite CLCT’s weak FY2020 results ended Dec 31.

DBS Group Research has maintained its “buy” call for the trust albeit with a lower target price of $1.55 from $1.70 previously.

OCBC Investment Research, too, has a “buy” rating for the trust with a higher fair value of $1.58 from $1.35 previously.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.